1 of 26

Adaptation and immune escape of SARS-CoV-2

Richard Neher @ MCID

2 of 26

Pathogen evolution

Epidemiology

Immunology

MCID – 2023-06-29

3 of 26

Alpha

Delta

Omicron

BA.1

BA.2

BA.5

Waves and variants from the past 3 years

covariants.org

MCID – 2023-06-29

4 of 26

Tracking spread and change of SARS-CoV-2

  • Similar sequences imply they are closely related
  • Allows to resolve dynamics on the scale of a month
  • Most mutations hurt the virus, some increase transmissibility or lead to immune escape

5 of 26

covariants.org

MCID – 2023-06-29

6 of 26

Ancestral Alpha Beta Delta Omicron

Ancestral

Alpha

Beta

Delta

Omicron

MCID – 2023-06-29

7 of 26

Early 2020: Little population immunity, selection for transmissibility

Outbreak in Europe rapidly dominated by more transmissible D614G variants

MCID – 2023-06-29

8 of 26

December 2020: Variants of Concern

  • Sudden emergence of variants with a large number of mutations�In Spike: Delta 69/70, N501Y, A570D, P681H, T716I, S982A, D1118H, E1202Q
  • No observed intermediates
  • Almost simultaneous occurrence of
    • Alpha
    • Beta
    • Gamma
  • They share several mutations, suggesting they are adaptive

Hill et al, 2022

Alpha

By Christian Althaus

  • Doubling every 1-2 weeks
  • Mostly regional, not global
  • Moderately more severe
  • Beta was immune evasive

MCID – 2023-06-29

9 of 26

2021: Delta – global dominance

  • A number of mutations that increase transmissibility
  • Moderately reduce immune recognition (less than Beta)

MCID – 2023-06-29

10 of 26

Seroprevalence: by end of 2021 most people had immunity

  • In some places, most immunity stemmed from infection, in other from vaccination
  • Since Nov 2021, most have experienced one or several Omicron infections

11 of 26

November 2021: Omicron

Omicron

Delta

Alpha

2019 origin

  • Heavily mutated sister variant of previous VOCs
  • Several distinct variants
  • High rate of reinfections
  • Very rapid spread

COG-UK

MCID – 2023-06-29

12 of 26

Emergence of VOCs: probably chronic infections

  • Chronic infections are common in immunocompromised
    • Immune suppression
    • Advanced HIV
  • Often hardly symptomatic
  • Rapid evolution is common�some times very diverse variants
  • Likely the source of Alpha and �Omicron, maybe more�
  • Since Omicron, evolution is more

stepwise and gradual

Chaguza et al, 2023

MCID – 2023-06-29

13 of 26

2022 and ongoing: Variant soup

BA.1

BA.2

BQ.1

BA.4/5

XBB

BA.2.75

Cao et al, 2022

MCID – 2023-06-29

14 of 26

From waves to more continuous circulation

Hospitalization numbers in England (via Our World in Data)

MCID – 2023-06-29

15 of 26

Influenza subtype dynamics

Influenza subtype dynamics in 2009

16 of 26

Pandemic to endemic: example influenza

  • mutations ⟷ immune escape
  • escape ➔ reinfections
  • frequent updates of the vaccine�(X ==vaccine virus)
  • gradual change

17 of 26

Influenza surface proteins change rapidly – similar to SARS-CoV-2

Variabilitaet

18 of 26

SARS-CoV-2 vaccine strains

X

X

X

X

ancestral vaccine

2022 boosters

Fall 2023 vaccine

19 of 26

What can we do with 15 million genomes?

MCID – 2023-06-29

20 of 26

Site specific mutation rates and fitness landscapes

  • Between 100 and 500 mutations per site! → allows quantitative estimation of site specific properties�
  • UShER (UC Santa Cruz) provides phylogenetic trees of millions of SC2 genomes

4-fold synonymous position

non-synonymous position

MCID – 2023-06-29

21 of 26

Mutation rates and their clade dependence

MCID – 2023-06-29

22 of 26

Mutation rates and their background dependence

MCID – 2023-06-29

23 of 26

MCID – 2023-06-29

24 of 26

MCID – 2023-06-29

25 of 26

Example: Fitness costs of mutations in the E protein

MCID – 2023-06-29

26 of 26

Acknowledgements

  • Nextstrain team (my lab and Trevor Bedford’s lab)
    • Ivan Aksamentov, Cornelius Roemer, Emma Hodcroft, Moira Zuber
    • John Huddleston, Jover Lee, Tom Sibley, James Hadfield
  • Jesse Bloom
  • Sequence data contributors around the world (shared via GISAID or INSDC)

MCID – 2023-06-29